University of Tokyo - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
33
About the Report
About the Report
Summary
The University of Tokyo (UTokyo) is a research university that offers undergraduate, graduate, professional and distance learning programs. The university offers courses in the field of science, agriculture, economics, law, medicine, engineering, pharmaceutical sciences, and others. It also gets funding from Japanese and foreign companies for various collaborative research projects. UTokyo partners with other institute to provide educational services. The university operates through its academic centers such as Asian Natural Environmental Science Center, Biotechnology Research Center, Center for Research and Development of Higher Education, Center for Spatial Information Science, Cryogenic Research Center, and others. UTokyo is headquartered in Bunkyo-Ku, Japan.
University of Tokyo-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
University of Tokyo, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Tokyo, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Tokyo, Medical Devices Deals, 2012 to YTD 2018 9
University of Tokyo, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University of Tokyo, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Astellas Pharma, Institute of Medical Science, Chiba University and Asahi Kogyosha Enter into Research Agreement 11
Astellas Pharma Enters into Agreement with Institute of Medical Science, the University of Tokyo 12
IMSUT and Astellas Pharma Enter into Agreement 13
Sanofi Enters into Drug Discovery Agreement with University of Tokyo 14
University of Tokyo Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 15
Licensing Agreements 16
TransGenic Enters into Licensing Agreement with University of Tokyo 16
BrightPath Biotherapeutics Enters into Licensing Agreement with University of Tokyo 17
TODAI TLO Enters into Licensing Agreement with NanoCarrier 18
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 19
Qiagen Enters into Licensing Agreement with University of Tokyo for SF3B1 21
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 22
University of Tokyo-Key Competitors 23
University of Tokyo-Key Employees 24
University of Tokyo-Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Government and Public Interest 26
Jun 15, 2018: Artificial biosynthesis yields superior steroid antibiotics 26
May 02, 2018: Variation in single amino acid impacts incidence of gastric cancer among Japanese 27
Jan 29, 2018: Blood vessel-on-a-chips show anti-cancer drug effects in human cells 28
Jan 11, 2018: NFIA identified as promising target for treating obesity 29
Nov 15, 2017: New treatment suppresses relapse of eye lymphoma in brain 30
Product News 31
Jun 13, 2018: University of Tokyo's RCAST Fujitsu and Kowa Successfully Create Promising New Compounds to Fight Drug-Resistant Cancer 31
Product Approvals 32
Jul 11, 2017: Oncolytic Virus G47delta (DS-1647) designated as Orphan Drug under Orphan Drug/Medical Device Designation System 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Figure
List of Figures
University of Tokyo, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Tokyo, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Tokyo, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
University of Tokyo, Pharmaceuticals & Healthcare, Key Facts 2
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Tokyo, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Tokyo, Deals By Therapy Area, 2012 to YTD 2018 8
University of Tokyo, Medical Devices Deals, 2012 to YTD 2018 9
University of Tokyo, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Astellas Pharma, Institute of Medical Science, Chiba University and Asahi Kogyosha Enter into Research Agreement 11
Astellas Pharma Enters into Agreement with Institute of Medical Science, the University of Tokyo 12
IMSUT and Astellas Pharma Enter into Agreement 13
Sanofi Enters into Drug Discovery Agreement with University of Tokyo 14
University of Tokyo Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 15
TransGenic Enters into Licensing Agreement with University of Tokyo 16
BrightPath Biotherapeutics Enters into Licensing Agreement with University of Tokyo 17
TODAI TLO Enters into Licensing Agreement with NanoCarrier 18
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 19
Qiagen Enters into Licensing Agreement with University of Tokyo for SF3B1 21
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 22
University of Tokyo, Key Competitors 23
University of Tokyo, Key Employees 24
University of Tokyo, Subsidiaries 25
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.